Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Neuropharmacology
|
March 25, 2019
Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances
Neil B Varshneya, D Matthew Walentiny, Lea T Moisa, et al.
Pharmacology, Biochemistry, and Behavior
|
November 26, 2022
Structurally diverse fentanyl analogs yield differential locomotor activities in mice
Neil B Varshneya, D Matthew Walentiny, David L Stevens, et al.
Experimental and Clinical Psychopharmacology
|
August 11, 2004
Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys
Patrick M Beardsley, Mario D Aceto, Charles D Cook, et al.
Journal of Medicinal Chemistry
|
January 25, 2002
Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules
Aloke K Dutta, Matthew C Davis, Xiang-Shu Fei, et al.
Neuropharmacology
|
December 14, 2020
Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice
D Matthew Walentiny, Essie Komla, Léa T Moisa, et al.
Journal of Medicinal Chemistry
|
October 1, 2004
Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters
Rohit Kolhatkar, Charles D Cook, Sujit K Ghorai, et al.
Journal of Medicinal Chemistry
|
March 21, 2003
High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo
Sujit K Ghorai, Charles Cook, Matthew Davis, et al.
The Journal of Biological Chemistry
|
September 13, 2022
Glucocorticoid receptor dysregulation underlies 5-HT<sub>2A</sub>R-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model
Justin M Saunders, Carolina Muguruza, Salvador Sierra, et al.
European Journal of Pharmacology
|
February 7, 2012
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice
Sarah E Snider, Sarah A Vunck, Edwin J C G van den Oord, et al.
Drug and Alcohol Dependence
|
January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Colleen Synan, Carrie Bowen, David J Heal, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Neuropharmacology
|
March 25, 2019
Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances
Neil B Varshneya, D Matthew Walentiny, Lea T Moisa, et al.
Pharmacology, Biochemistry, and Behavior
|
November 26, 2022
Structurally diverse fentanyl analogs yield differential locomotor activities in mice
Neil B Varshneya, D Matthew Walentiny, David L Stevens, et al.
Experimental and Clinical Psychopharmacology
|
August 11, 2004
Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys
Patrick M Beardsley, Mario D Aceto, Charles D Cook, et al.
Journal of Medicinal Chemistry
|
January 25, 2002
Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules
Aloke K Dutta, Matthew C Davis, Xiang-Shu Fei, et al.
Neuropharmacology
|
December 14, 2020
Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice
D Matthew Walentiny, Essie Komla, Léa T Moisa, et al.
Journal of Medicinal Chemistry
|
October 1, 2004
Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters
Rohit Kolhatkar, Charles D Cook, Sujit K Ghorai, et al.
Journal of Medicinal Chemistry
|
March 21, 2003
High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo
Sujit K Ghorai, Charles Cook, Matthew Davis, et al.
The Journal of Biological Chemistry
|
September 13, 2022
Glucocorticoid receptor dysregulation underlies 5-HT<sub>2A</sub>R-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model
Justin M Saunders, Carolina Muguruza, Salvador Sierra, et al.
European Journal of Pharmacology
|
February 7, 2012
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice
Sarah E Snider, Sarah A Vunck, Edwin J C G van den Oord, et al.
Drug and Alcohol Dependence
|
January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Colleen Synan, Carrie Bowen, David J Heal, et al.
Page
of 7